Virbac SA (VIRP.PA)

370 €

-1.50 (-0.40%)
Rating:
Recommendation:
-
Symbol VIRP.PA
Price 370 €
Beta 0.853
Volume Avg. 0.01M
Market Cap 3.126B
Shares () -
52 Week Range 290.0-448.5
1y Target Est -
DCF Unlevered VIRP.PA DCF ->
DCF Levered VIRP.PA LDCF ->
ROE 6.73% Neutral
ROA 3.64% Neutral
Operating Margin -
Debt / Equity 65.71% Buy
P/E 27.61 Strong Buy
P/B 4.30 Strong Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades


Mr. Christian Karst
Healthcare
Drug Manufacturers—General
Paris

Virbac SA manufactures and sells a range of products and services for companion and food-producing animals in France, Europe, Latin America, North America, the Asia Pacific, the Middle East, and Africa. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.